vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Avidbank Holdings, Inc. (AVBH). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $28.0M, roughly 1.6× Avidbank Holdings, Inc.). Avidbank Holdings, Inc. runs the higher net margin — 32.3% vs -19.9%, a 52.2% gap on every dollar of revenue.
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Avidbank Holdings, Inc. is a U.S.-based financial holding company operating through its subsidiary AvidBank. It offers commercial banking products and services primarily to small and medium-sized enterprises, business owners, and high-net-worth individuals across California, including commercial loans, deposit accounts, cash management, and customized financing solutions for sectors like manufacturing, technology, real estate and professional services.
ABCL vs AVBH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $28.0M |
| Net Profit | $-8.9M | $9.0M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | — |
| Net Margin | -19.9% | 32.3% |
| Revenue YoY | 788.4% | — |
| Net Profit YoY | 73.9% | 65.9% |
| EPS (diluted) | $-0.03 | $0.84 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $28.0M | ||
| Q4 25 | $44.9M | $26.8M | ||
| Q3 25 | $9.0M | $48.0K | ||
| Q2 25 | $17.1M | $21.8M | ||
| Q1 25 | $4.2M | — | ||
| Q4 24 | $5.0M | — | ||
| Q3 24 | $6.5M | — | ||
| Q2 24 | $7.3M | — |
| Q1 26 | — | $9.0M | ||
| Q4 25 | $-8.9M | $6.9M | ||
| Q3 25 | $-57.1M | $-37.7M | ||
| Q2 25 | $-34.7M | $5.8M | ||
| Q1 25 | $-45.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-51.1M | — | ||
| Q2 24 | $-36.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | -63.7% | — | ||
| Q3 25 | -851.8% | -110491.7% | ||
| Q2 25 | -290.2% | 38.0% | ||
| Q1 25 | -1479.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1439.4% | — | ||
| Q2 24 | -1276.2% | — |
| Q1 26 | — | 32.3% | ||
| Q4 25 | -19.9% | 25.9% | ||
| Q3 25 | -637.8% | -78614.6% | ||
| Q2 25 | -203.3% | 26.6% | ||
| Q1 25 | -1077.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -785.4% | — | ||
| Q2 24 | -504.3% | — |
| Q1 26 | — | $0.84 | ||
| Q4 25 | $-0.03 | $0.65 | ||
| Q3 25 | $-0.19 | $-4.12 | ||
| Q2 25 | $-0.12 | $0.75 | ||
| Q1 25 | $-0.15 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.17 | — | ||
| Q2 24 | $-0.13 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | $55.0M |
| Stockholders' EquityBook value | $966.9M | $287.2M |
| Total Assets | $1.4B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — |
| Q1 26 | — | $55.0M | ||
| Q4 25 | — | $60.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $287.2M | ||
| Q4 25 | $966.9M | $278.4M | ||
| Q3 25 | $964.0M | $273.1M | ||
| Q2 25 | $1.0B | $204.4M | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — |
| Q1 26 | — | $2.5B | ||
| Q4 25 | $1.4B | $2.5B | ||
| Q3 25 | $1.4B | $2.4B | ||
| Q2 25 | $1.4B | $2.4B | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | — |
| Q1 26 | — | 0.19× | ||
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | — |
| Free Cash FlowOCF − Capex | $-44.6M | — |
| FCF MarginFCF / Revenue | -99.4% | — |
| Capex IntensityCapex / Revenue | 21.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-34.7M | — | ||
| Q3 25 | $-52.6M | $12.4M | ||
| Q2 25 | $-32.4M | $10.7M | ||
| Q1 25 | $-11.6M | — | ||
| Q4 24 | $-108.6M | — | ||
| Q3 24 | $-28.9M | — | ||
| Q2 24 | $-30.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | $-44.6M | — | ||
| Q3 25 | $-61.5M | $12.4M | ||
| Q2 25 | $-45.8M | $10.6M | ||
| Q1 25 | $-22.2M | — | ||
| Q4 24 | $-187.0M | — | ||
| Q3 24 | $-47.4M | — | ||
| Q2 24 | $-50.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | -99.4% | — | ||
| Q3 25 | -687.0% | 25783.3% | ||
| Q2 25 | -267.9% | 48.6% | ||
| Q1 25 | -524.0% | — | ||
| Q4 24 | -3702.8% | — | ||
| Q3 24 | -728.4% | — | ||
| Q2 24 | -683.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 21.9% | — | ||
| Q3 25 | 99.7% | 72.9% | ||
| Q2 25 | 78.2% | 0.3% | ||
| Q1 25 | 251.1% | — | ||
| Q4 24 | 1552.7% | — | ||
| Q3 24 | 284.6% | — | ||
| Q2 24 | 274.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.84× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
AVBH
| Net Interest Income | $26.5M | 95% |
| Noninterest Income | $1.5M | 5% |
